Suchergebnisse - "Komura, Kazumasa"

PubPharm (178)

1

Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer : A multicenter observational study

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2024

von Fukuokaya, W. | Koike, Y. | Yata, Y. | +15

2

Comparison of the Efficacy of Enfortumab Vedotin between patients with Metastatic Urothelial Carcinoma who were treated with Avelumab or Pembrolizumab: Real-World Data from a Multi-Institutional Study in Japan

enthalten in: ResearchSquare.com | 2024

von Hirasawa, Y. | Adachi, T. | Hashimoto, T. | +16

3

Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab : real-world data from a multi-institutional study in Japan

enthalten in: Journal of cancer research and clinical oncology | 2024

von Hirasawa, Y. | Adachi, T. | Hashimoto, T. | +16

4

Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan

enthalten in: Journal of cancer research and clinical oncology | 2024

von Hirasawa, Y. | Adachi, T. | Hashimoto, T. | +16

5

Importance of Management of Lifestyle-Related Diseases After Kidney Donation to Living Donors

enthalten in: Transplantation proceedings | 2024

von Hirano, H. | Fujiwara, Y. | Okabe, T. | +7

6

Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors

enthalten in: Targeted oncology | 2024

von Uchimoto, T. | Tsuchida, S. | Komura, K. | +29

7

Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab : A Multicenter Retrospective Study

enthalten in: Clinical genitourinary cancer | 2024

von Nukaya, T. | Takahara, K. | Yoshizawa, A. | +26

8

Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft Models

enthalten in: International journal of molecular sciences | 2024

von Ueda, S. | Tanaka, T. | Hirosuna, K. | +14

9

Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma

enthalten in: The journal of pathology. Clinical research | 2024

von Ura, A. | Hayashi, T. | Komura, K. | +11

10

Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma

enthalten in: The Journal of Pathology: Clinical Research | 2024

von Ura, A. | Hayashi, T. | Komura, K. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]